Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nathan Dwyer

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 22, 2023
Accuracy of cuff blood pressure and systolic blood pressure amplificationTan V Bui, Dean S Picone, Martin G Schultz, et al.
The European Respiratory Journal|April 29, 2020
Pulmonary arterial hypertension with below threshold pulmonary vascular resistanceSeshika Ratwatte, James Anderson, Geoffrey Strange, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
Blood Pressure Monitoring|May 6, 2025
Validation assessment of a cuff-based central blood pressure device according to Artery Society recommendationsTan V Bui, Dean S Picone, Wojciech P Kosmala, et al.
BMJ Open|December 10, 2016
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolAlicia Calderone, Wendy Stevens, David Prior, et al.
Heart, Lung & Circulation|April 14, 2020
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and ChallengesJames Anderson, Melanie Lavender, Edmund Lau, et al.
Heart, Lung & Circulation|October 15, 2017
Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New ZealandGeoff Strange, Edmund M Lau, Eleni Giannoulatou, et al.
Chest|November 11, 2023
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension TherapyKatherine Kearney, Karen Brown, David S Celermajer, et al.
Respirology (Carlton, Vic.)|January 31, 2020
Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registryVictor Khou, James J Anderson, Geoff Strange, et al.
Respirology (Carlton, Vic.)|October 5, 2021
Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registryKatherine Kearney, Joshua Gold, Carolyn Corrigan, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 22, 2023
Accuracy of cuff blood pressure and systolic blood pressure amplificationTan V Bui, Dean S Picone, Martin G Schultz, et al.
The European Respiratory Journal|April 29, 2020
Pulmonary arterial hypertension with below threshold pulmonary vascular resistanceSeshika Ratwatte, James Anderson, Geoffrey Strange, et al.
Pulmonary Circulation|June 10, 2026
A Multicenter, Double-Blind, Placebo-Controlled, Randomized Clinical Trial of Oral Anticoagulation in Systemic Sclerosis-Related Pulmonary Arterial Hypertension-Results From the SPHInX StudyMandana Nikpour, Alicia Calderone, Susanna M Proudman, et al.
Blood Pressure Monitoring|May 6, 2025
Validation assessment of a cuff-based central blood pressure device according to Artery Society recommendationsTan V Bui, Dean S Picone, Wojciech P Kosmala, et al.
BMJ Open|December 10, 2016
Multicentre randomised placebo-controlled trial of oral anticoagulation with apixaban in systemic sclerosis-related pulmonary arterial hypertension: the SPHInX study protocolAlicia Calderone, Wendy Stevens, David Prior, et al.
Heart, Lung & Circulation|April 14, 2020
Pharmacological Treatment of Pulmonary Arterial Hypertension in Australia: Current Trends and ChallengesJames Anderson, Melanie Lavender, Edmund Lau, et al.
Heart, Lung & Circulation|October 15, 2017
Survival of Idiopathic Pulmonary Arterial Hypertension Patients in the Modern Era in Australia and New ZealandGeoff Strange, Edmund M Lau, Eleni Giannoulatou, et al.
Chest|November 11, 2023
Impact of Left Heart Disease Risk Factors on Outcomes in Pulmonary Arterial Hypertension TherapyKatherine Kearney, Karen Brown, David S Celermajer, et al.
Respirology (Carlton, Vic.)|January 31, 2020
Diagnostic delay in pulmonary arterial hypertension: Insights from the Australian and New Zealand pulmonary hypertension registryVictor Khou, James J Anderson, Geoff Strange, et al.
Respirology (Carlton, Vic.)|October 5, 2021
Chronic thromboembolic pulmonary hypertension in Australia and New Zealand: An analysis of the PHSANZ registryKatherine Kearney, Joshua Gold, Carolyn Corrigan, et al.
Pageof 5